<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cai L</submitter><funding>National Natural Science Foundation of China</funding><pagination>174</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12915010</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic synovial inflammation, cartilage destruction, and bone loss. Current therapeutic approaches are often limited by short drug half-life, insufficient local drug release, and substantial systemic side effects.In this study, we developed a composite thermosensitive hydrogel system that integrates in situ gelation, sustained drug release, and multitarget therapeutic effects for localized precision treatment of RA.The system consists of a thermosensitive hydrogel matrix composed of hydroxypropyl methylcellulose (HPMC), hyaluronic acid (HA), and glycerol, in which gelatin methacryloyl (GelMA) hydrogel microspheres are embedded. The microspheres efficiently encapsulate Drynaria rhizome-derived extracellular vesicles (DR-EV</pubmed_abstract><journal>Journal of nanobiotechnology</journal><pubmed_title>Hydrogel microspheres loaded with sinomenine and Drynaria rhizome enhance the treatment of rheumatoid arthritis via immune regulation and promoting bone repair.</pubmed_title><pmcid>PMC12915010</pmcid><funding_grant_id>82374206</funding_grant_id><funding_grant_id>82304928</funding_grant_id><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Zhang K</pubmed_authors><pubmed_authors>Zhao W</pubmed_authors><pubmed_authors>Gao J</pubmed_authors><pubmed_authors>Cai L</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Xu S</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Zhu W</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Xiao B</pubmed_authors><pubmed_authors>Pei T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hydrogel microspheres loaded with sinomenine and Drynaria rhizome enhance the treatment of rheumatoid arthritis via immune regulation and promoting bone repair.</name><description>Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic synovial inflammation, cartilage destruction, and bone loss. Current therapeutic approaches are often limited by short drug half-life, insufficient local drug release, and substantial systemic side effects.In this study, we developed a composite thermosensitive hydrogel system that integrates in situ gelation, sustained drug release, and multitarget therapeutic effects for localized precision treatment of RA.The system consists of a thermosensitive hydrogel matrix composed of hydroxypropyl methylcellulose (HPMC), hyaluronic acid (HA), and glycerol, in which gelatin methacryloyl (GelMA) hydrogel microspheres are embedded. The microspheres efficiently encapsulate Drynaria rhizome-derived extracellular vesicles (DR-EV</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T06:32:58.829Z</modification><creation>2026-07-09T10:39:48.76Z</creation></dates><accession>S-EPMC12915010</accession><cross_references><pubmed>41582151</pubmed><doi>10.1186/s12951-026-04063-4</doi></cross_references></HashMap>